Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Cash from Operations (Quarterly): 2.77M for Sept. 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 2.77M |
| June 30, 2023 | -66.74M |
| March 31, 2023 | -73.72M |
| December 31, 2022 | -60.20M |
| September 30, 2022 | -64.21M |
| June 30, 2022 | -63.99M |
| March 31, 2022 | -41.40M |
| December 31, 2021 | -45.87M |
| September 30, 2021 | -35.04M |
| June 30, 2021 | -43.88M |
| March 31, 2021 | -44.62M |
| December 31, 2020 | 8.535M |
| September 30, 2020 | -30.65M |
| June 30, 2020 | -28.19M |
| March 31, 2020 | -28.32M |
| December 31, 2019 | -32.56M |
| September 30, 2019 | -35.00M |
| June 30, 2019 | -31.01M |
| March 31, 2019 | 10.20M |
| December 31, 2018 | -41.28M |
| September 30, 2018 | -39.86M |
| June 30, 2018 | -35.33M |
| March 31, 2018 | -49.96M |
| December 31, 2017 | -29.41M |
| September 30, 2017 | 45.93M |
| Date | Value |
|---|---|
| June 30, 2017 | 24.08M |
| March 31, 2017 | -32.96M |
| September 30, 2016 | -47.84M |
| June 30, 2016 | -32.91M |
| March 31, 2016 | -26.08M |
| December 31, 2015 | -34.14M |
| September 30, 2015 | -31.35M |
| June 30, 2015 | -28.45M |
| March 31, 2015 | 7.545M |
| December 31, 2014 | -15.48M |
| September 30, 2014 | -18.90M |
| June 30, 2014 | -18.92M |
| March 31, 2014 | -13.10M |
| December 31, 2013 | 1.946M |
| September 30, 2013 | -23.58M |
| June 30, 2013 | -11.61M |
| March 31, 2013 | -5.978M |
| December 31, 2012 | -21.70M |
| September 30, 2012 | -21.01M |
| June 30, 2012 | -16.17M |
| March 31, 2012 | 5.919M |
| December 31, 2011 | -12.47M |
| September 30, 2011 | -11.56M |
| June 30, 2011 | -13.93M |
| March 31, 2011 | -12.45M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-73.72M
Minimum
Mar 2023
8.535M
Maximum
Dec 2020
-39.67M
Average
-38.22M
Median
Cash from Operations (Quarterly) Benchmarks
| AbbVie Inc | 4.04B |
| Pfizer Inc | 1.09B |
| Johnson & Johnson | 3.657B |
| Merck & Co Inc | 3.09B |
| Cerevel Therapeutics Holdings Inc | -119.67M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.354M |
| Cash from Financing (Quarterly) | 32.13M |
| Free Cash Flow | -199.78M |
| Free Cash Flow Per Share (Quarterly) | 0.0049 |
| Free Cash Flow to Equity (Quarterly) | 1.26M |
| Free Cash Flow to Firm (Quarterly) | 1.416M |